American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Salesforce
CRM
|
+$306M |
| 2 |
Church & Dwight Co
CHD
|
+$182M |
| 3 |
Lattice Semiconductor
LSCC
|
+$165M |
| 4 |
UnitedHealth
UNH
|
+$157M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| 1 |
Humana
HUM
|
+$292M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$265M |
| 3 |
Air Products & Chemicals
APD
|
+$200M |
| 4 |
HES
Hess
HES
|
+$191M |
| 5 |
Idexx Laboratories
IDXX
|
+$182M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Forge Global Holdings
FRGE
$239M
| $254K | ﹤0.01% |
4,936
+1,750
| +55% | +$90K |
|
2577
Confluent
CFLT
$6.63B
| $253K | ﹤0.01% |
10,811
+337
| +3% | +$7.89K |
|
2578
Matrix Service
MTRX
$353M
| $252K | ﹤0.01% |
+25,756
| New | +$252K |
|
2579
Allogene Therapeutics
ALLO
$251M
| $251K | ﹤0.01% |
78,147
+22,611
| +41% | +$72.6K |
|
2580
Rocket Pharmaceuticals
RCKT
$341M
| $251K | ﹤0.01% |
+8,370
| New | +$251K |
|
2581
Tejon Ranch
TRC
$448M
| $246K | ﹤0.01% |
14,303
+1,382
| +11% | +$23.8K |
|
|
TGB
2582
Taseko Mines
TGB
$1.12B
| $246K | ﹤0.01% |
175,202
-25,100
| -13% | -$35.2K |
|
|
SWTX
2583
DELISTED
SpringWorks Therapeutics
SWTX
| $245K | ﹤0.01% |
+6,706
| New | +$245K |
|
|
AMK
2584
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $243K | ﹤0.01% |
8,123
-12
| -0.1% | -$359 |
|
2585
Bank7 Corp
BSVN
$455M
| $243K | ﹤0.01% |
+8,876
| New | +$243K |
|
2586
Organon & Co
OGN
$2.77B
| $241K | ﹤0.01% |
16,693
+266
| +2% | +$3.84K |
|
2587
Atea Pharmaceuticals
AVIR
$249M
| $240K | ﹤0.01% |
78,754
+22,861
| +41% | +$69.7K |
|
2588
QuantumScape
QS
$5.63B
| $240K | ﹤0.01% |
34,473
+2,092
| +6% | +$14.5K |
|
|
CONN
2589
DELISTED
Conn's Inc.
CONN
| $239K | ﹤0.01% |
53,840
-85,134
| -61% | -$378K |
|
2590
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $239K | ﹤0.01% |
5,586
-92
| -2% | -$3.94K |
|
2591
Gannett
GCI
$620M
| $238K | ﹤0.01% |
103,537
+80,522
| +350% | +$185K |
|
2592
Cogent Communications
CCOI
$1.77B
| $236K | ﹤0.01% |
3,107
-10,738
| -78% | -$817K |
|
2593
Oportun Financial
OPRT
$293M
| $236K | ﹤0.01% |
60,438
-11,968
| -17% | -$46.8K |
|
2594
AnaptysBio
ANAB
$655M
| $236K | ﹤0.01% |
11,012
+159
| +1% | +$3.41K |
|
2595
Ichor Holdings
ICHR
$579M
| $234K | ﹤0.01% |
6,970
-60
| -0.9% | -$2.02K |
|
2596
F&G Annuities & Life
FG
$4.65B
| $234K | ﹤0.01% |
+5,087
| New | +$234K |
|
2597
Zynex
ZYXI
$44.8M
| $232K | ﹤0.01% |
21,303
+4,390
| +26% | +$47.8K |
|
2598
Olaplex Holdings
OLPX
$947M
| $232K | ﹤0.01% |
91,175
+43,727
| +92% | +$111K |
|
|
ENFN
2599
DELISTED
Enfusion, Inc.
ENFN
| $229K | ﹤0.01% |
+23,606
| New | +$229K |
|
2600
AngioDynamics
ANGO
$433M
| $228K | ﹤0.01% |
29,102
+9,690
| +50% | +$76K |
|